z-logo
open-access-imgOpen Access
Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4)
Author(s) -
Hugues Melliez,
Murielle MaryKrause,
Laurence Bocket,
Marguerite Guiguet,
Sophie Abgrall,
Pierre de Truchis,
Christine Katlama,
Guillaume MartinBlondel,
Aurélia Henn,
Matthieu Revest,
Olivier Robineau,
Marie-Aude Khuong-Josses,
Anna Canestri,
Nathalie De Castro,
Véronique Joly,
Saadia Mokhtari,
Karine Risso,
Jacques Gasnault,
Dominique Costagliola
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy074
Subject(s) - medicine , progressive multifocal leukoencephalopathy , hazard ratio , cart , incidence (geometry) , cohort , confidence interval , cohort study , pediatrics , immunology , virology , virus , mechanical engineering , physics , optics , engineering
Risk factors for progressive multifocal leukoencephalopathy (PML) in individuals with human immunodeficiency virus (HIV) infection are poorly documented in the era of combination antiretroviral therapy (cART).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom